NIGHTINGALE HEALTH EO 1 (7XE) — Tangible Net Worth Ratio
NIGHTINGALE HEALTH EO 1 (7XE) has a Tangible Net Worth Ratio of 88.0% as of December 2025. This metric is calculated by deducting intangible assets (€6.94 Million) from net assets (€57.99 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore 7XE net asset momentum to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
NIGHTINGALE HEALTH EO 1 Tangible Net Worth Ratio (2022–2025)
This chart shows how NIGHTINGALE HEALTH EO 1's Tangible Net Worth Ratio has changed across 4 annual periods from 2022 to 2025. As of December 2025, the ratio stands at 88.0%, reflecting net assets of €57.99 Million with intangible assets of €6.94 Million EUR. For live market cap and overall valuation, see NIGHTINGALE HEALTH EO 1 market capitalisation.
Annual Tangible Net Worth Ratio for NIGHTINGALE HEALTH EO 1 (2022–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for NIGHTINGALE HEALTH EO 1 from 2022 to 2025, covering 4 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. See 7XE FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 87.5% | €66.17 Million | €8.28 Million | €74.51 Million | ▲ +2.3 pp |
| 2024 | 85.2% | €82.88 Million | €12.30 Million | €90.84 Million | ▲ +1.6 pp |
| 2023 | 83.5% | €97.36 Million | €16.04 Million | €106.79 Million | ▼ -1.9 pp |
| 2022 | 85.4% | €111.44 Million | €16.25 Million | €124.05 Million | — |